What Happened?
Shares of health insurance company Oscar Health (NYSE: OSCR) jumped 10.8% in the afternoon session after the company provided a business update and reaffirmed its full-year 2026 guidance during a presentation at the Goldman Sachs Healthcare Conference.
The update gave investors added confidence that the health insurer's growth and profitability targets remain on track. During a fireside chat at the event, management disclosed that 2026 was progressing strongly, citing favorable trends and lighter-than-expected market morbidity. By reaffirming its previously stated full-year guidance, Oscar Health signaled stability in its financial outlook, which was received positively by the market.
Is now the time to buy Oscar Health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Oscar Health’s shares are extremely volatile and have had 58 moves greater than 5% over the last year. But moves this big are rare even for Oscar Health and indicate this news significantly impacted the market’s perception of the business.
The previous big move we wrote about was 18 days ago when the stock dropped 3.3% on the news that the company's Chief Financial Officer, Richard Blackley, sold $2.75 million in company stock, a move that can sometimes worry investors about a company's outlook.
This executive sale occurred against a backdrop of potential challenges in the health insurance market. Reports suggest millions of people may drop their Affordable Care Act (ACA) coverage after enhanced government subsidies, which helped lower costs, were not renewed. This could lead to fewer customers for insurers like Oscar Health. Furthermore, while the company's recent first-quarter earnings per share significantly beat expectations, it also reported a revenue shortfall for the period. The combination of the insider sale and broader market headwinds likely contributed to the stock's decline.
Oscar Health is up 81.7% since the beginning of the year, and at $27.20 per share, it has set a new 52-week high. Despite the year-to-date gain, investors who bought $1,000 worth of Oscar Health’s shares 5 years ago would now be looking at only $948.36.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
